Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BWX Technologies
Ottawa/Kanata, Ontario, Canadabwxt.com ↗
- Ownership
- Private
- Employees
- ~4500
- Development stage
- Commercial
01
Overview
BWXT Medical manufactures cGMP-grade medical isotopes, APIs, and finished products used globally in diagnostic imaging and targeted radiotherapies. The company has established partnerships with leading biotechs to supply actinium‑225 for clinical-stage targeted alpha therapy programs. It operates large-scale facilities capable of supporting both clinical trials and commercial production.
- Therapeutic areas
- OncologyOther
- Modalities
- RadiopharmaceuticalActive pharmaceutical ingredient (API)Small molecule (for some isotopes used in radiolabeling)Device (for certain nuclear medicine applications)
- Industry
- Contract Manufacturing Organization
02
Partnerships
Fusion Pharmaceuticals (actinium‑225 supply)NorthStar Medical Radioisotopes (actinium‑225 production partnership)
Beyond the preview
Go deeper on BWX Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BWX Technologies.